Evidence map›Paper›PMID 32391270›Full record

ArticleFrontiers in oncology2020

FOLFOX Chemotherapy Ameliorates CD8 T Lymphocyte Exhaustion and Enhances Checkpoint Blockade Efficacy in Colorectal Cancer.

Yue Guan, Sean G Kraus, Michael J Quaney, Mark A Daniels, Jonathan B Mitchem, Emma Teixeiro

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. CanFrontiers in pharmacology · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Optimizing the spatial immune landscape of CD103Cellular oncology (Dordrecht, Netherlands) · 2024
    Article
  15. Article
  16. Article
  17. Frontiers in pharmacology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yue GuanDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
Sean G KrausDepartment of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.
Michael J QuaneyDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
Mark A DanielsDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
Jonathan B MitchemDepartment of Surgery, School of Medicine, University of Missouri, Columbia, MO, United States.
Emma TeixeiroDepartment of Molecular Microbiology and Immunology, School of Medicine, University of Missouri, Columbia, MO, United States.
University of Missouri · USHarry S. Truman Memorial Veterans' Hospital · US

Funding

Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
TCR signal transduction in the regulation of T cell memoryR01AI110420 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI TEIXEIRO, EMMA · 2015 to 2019
$1.8M
Optimizing anti-tumor immunity for maximal therapeutic efficacy in Colorectal CancerIK2BX004346 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI MITCHEM, JONATHAN B. · 2019 to 2024
–
BLRD VA IK2 BX004346NCATS NIH HHS KL2 TR000450NCATS NIH HHS KL2 TR002346NIAID NIH HHS R01 AI110420
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemotherapycolorectal cancerCTLexhaustionimmune checkpoint blockadeTIL

Identifiers

PMID32391270
PMCPMC7190812
OpenAlexW3017846780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.